Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
10
2019
McDermottPlus Check-Up: May 10, 2019 McDermott Will & Emery
May
10
2019
FDA Issues Guidance on FCNs for Substances Intended to Contact Infant Formula Keller and Heckman LLP
May
10
2019
Product Recalls Decline Across All Industries in Q1 2019 Keller and Heckman LLP
May
9
2019
Co-Pay Kickbacks at Center of $122M in Settlement Fees for Alleged Medicare Fraud Tycko & Zavareei LLP
May
9
2019
CMS Finalizes Rule Requiring Disclosure of Drug Prices in TV Ads Mintz
May
9
2019
Compliance Inspections for CBD Retail Operations in NC Ward and Smith, P.A.
May
9
2019
Florida Now Requires Physicians to Inform Patients About Non-Opioid Alternatives Polsinelli PC
May
9
2019
California’s Proposition 65 Website Posts Styrene Fact Sheet Keller and Heckman LLP
May
9
2019
FDA Adds “Black Box” Warning Label to Sleep Drugs Including Ambien, Lunesta Stark & Stark
May
8
2019
CBD Risk Management Wilson Elser Moskowitz Edelman & Dicker LLP
May
8
2019
AAFCO Issues Updated Guidelines Regarding Hemp in Animal Food Sheppard, Mullin, Richter & Hampton LLP
May
8
2019
FMCSA Clearinghouse Rules Take Effect On January 6, 2020: Are You Ready? Jackson Lewis P.C.
May
8
2019
Sharpless: ‘No Pause’ Following Gottlieb’s Departure Keller and Heckman LLP
May
7
2019
Prop 65 Fact Sheet for Styrene Includes Perplexing Recommendation Keller and Heckman LLP
May
7
2019
FDA Denies Request for Public Hearing on Perchlorate Keller and Heckman LLP
May
7
2019
N.J. May Ban Both Paper and Plastic Grocery Bags Keller and Heckman LLP
May
6
2019
First of Its Kind: Drug Wholesaler Accepts DPA and Two Executives Face Criminal Charges in SDNY For Illegal Distribution of Opioids McDermott Will & Emery
May
6
2019
Follow-Up on the Legalization of Marijuana in Connecticut Wilson Elser Moskowitz Edelman & Dicker LLP
May
6
2019
Canada Expands Use of Fines for Food Safety Noncompliance Keller and Heckman LLP
May
6
2019
PMC Releases "A Consumer's Guide to Genetic Health Testing" Foley & Lardner LLP
May
3
2019
EPA Corrects 200 Parts-per-billion Level Description in Technical Amendment to Data Requirements for Antimicrobial Pesticides Final Rule Bergeson & Campbell, P.C.
May
2
2019
Ninth Circuit Gives A Partial Green Light to Cannabis Company Bankruptcies Squire Patton Boggs (US) LLP
May
2
2019
USDA Posts FAQ regarding BE Labeling and Promises Future Guidance Keller and Heckman LLP
May
2
2019
What Is the Deal With Xeljanz Lawsuits? Stark & Stark
May
1
2019
Foreign Investments In US Biotech Now Covered by CFIUS McDermott Will & Emery
May
1
2019
Yes, UCANN! Sheppard, Mullin, Richter & Hampton LLP
May
1
2019
China's Pharmaceutical Marketing Authorisation Holder Mechanism McDermott Will & Emery
May
1
2019
FDA Announces “New Era of Smarter Food Safety” Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins